Vestmark Advisory Solutions Inc. Sells 2,880 Shares of GE HealthCare Technologies Inc. $GEHC

Vestmark Advisory Solutions Inc. decreased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 49.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,998 shares of the company’s stock after selling 2,880 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in GE HealthCare Technologies were worth $222,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. N.E.W. Advisory Services LLC purchased a new position in GE HealthCare Technologies in the 1st quarter worth approximately $25,000. Bogart Wealth LLC raised its stake in shares of GE HealthCare Technologies by 260.0% in the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after purchasing an additional 247 shares during the last quarter. Gladwyn Financial Advisors Inc. bought a new position in shares of GE HealthCare Technologies during the second quarter valued at $34,000. Game Plan Financial Advisors LLC boosted its position in shares of GE HealthCare Technologies by 295.3% during the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after buying an additional 375 shares during the last quarter. Finally, Zions Bancorporation National Association UT bought a new stake in GE HealthCare Technologies in the 1st quarter worth about $42,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.4%

Shares of GEHC stock opened at $74.65 on Thursday. The company has a market cap of $34.00 billion, a PE ratio of 15.41, a price-to-earnings-growth ratio of 2.76 and a beta of 1.13. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The stock’s 50 day simple moving average is $75.20 and its two-hundred day simple moving average is $73.65. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. During the same period in the previous year, the firm earned $1.14 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.89%.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Wells Fargo & Company reduced their price target on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research report on Thursday, October 30th. Barclays started coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They set an “equal weight” rating and a $86.00 price target on the stock. BTIG Research set a $87.00 price objective on GE HealthCare Technologies in a research note on Wednesday, October 29th. Zacks Research cut shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Finally, Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average price target of $86.10.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.